| Fresenius (FMS) is a Great Momentum Stock: Should You Buy? |
Does Fresenius (FMS) have what it takes to be a top stock pick for momentum investors? Let's find out. |
zacks.com |
2025-05-15 17:00:49 |
Czytaj oryginał (ang.) |
| Fresenius (FMS) is a Top-Ranked Momentum Stock: Should You Buy? |
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service. |
zacks.com |
2025-05-15 14:56:11 |
Czytaj oryginał (ang.) |
| 5 High-Flying Medical Instrument Stocks to Buy Despite Recent Turmoil |
Five high-flying medical instrument stocks are: DXCM, IDXX, NPCE, CLPT, FMS. |
zacks.com |
2025-05-15 13:11:13 |
Czytaj oryginał (ang.) |
| Focus Graphite Announces the Grant of Incentive Stock Options to its Officers and Consultants |
OTTAWA, ON / ACCESS Newswire / May 14, 2025 / Focus Graphite Advanced Materials Inc. (TSXV:FMS)(OTCQB:FCSMF)(FSE:FKC) ("Focus" or the "Company"), announced the grant of incentive stock options as compensation to its officers and consultants. Options to purchase up to 963,084 Common Shares of the Company were granted at an exercise price of $0.09 per share. |
accessnewswire.com |
2025-05-14 15:55:00 |
Czytaj oryginał (ang.) |
| New Strong Buy Stocks for May 9th |
CBNA, FMS, BNTGY, WYY and BCRX have been added to the Zacks Rank #1 (Strong Buy) List on May 9, 2025. |
zacks.com |
2025-05-09 12:10:40 |
Czytaj oryginał (ang.) |
| Best Value Stocks to Buy for May 9th |
BNTGY, SSUMY and FMS made it to the Zacks Rank #1 (Strong Buy) value stocks list on May 9, 2025. |
zacks.com |
2025-05-09 10:45:42 |
Czytaj oryginał (ang.) |
| Best Income Stocks to Buy for May 9th |
SSUMY and FMS made it to the Zacks Rank #1 (Strong Buy) income stocks list on May 9, 2025. |
zacks.com |
2025-05-09 09:40:17 |
Czytaj oryginał (ang.) |
| FMS Stock Up as Q1 Earnings Beat Estimates, Revenues Up Y/Y |
Fresenius Medical's first-quarter results showcase a strong segmental performance, along with reiterating its 2025 outlook for revenue growth. |
zacks.com |
2025-05-07 17:30:37 |
Czytaj oryginał (ang.) |
| Why Fresenius (FMS) is a Top Value Stock for the Long-Term |
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage. |
zacks.com |
2025-05-06 14:46:10 |
Czytaj oryginał (ang.) |
| Fresenius Medical Care starts 2025 with strong organic revenue and income growth |
Strong organic revenue growth1 of 5% driven by Care Enablement and Care Delivery Stable U.S. same market treatment development despite impact from a severe flu season FME25 savings of EUR 68 million contributed to earnings Operating income2 grew 11% at constant currency resulting in margin expansion Reported operating income grew by 35% and reported net income3 by 113% Net leverage ratio further improved to 2.8x and FY 2025 outlook confirmed BAD HOMBURG, Germany , May 6, 2025 /PRNewswire/ -- "The results of the first quarter of 2025 once again demonstrate our continuous operational and financial progress as we are executing the third and last year of our current strategic plan," said Helen Giza, Chief Executive Officer of Fresenius Medical Care. "Revenue of both segments grew organically, and the phasing of the operating income development was in-line with our expectations. |
prnewswire.com |
2025-05-06 11:00:00 |
Czytaj oryginał (ang.) |
| Fresenius Medical Care tops market expectations in 1st quarter |
World's largest dialysis specialist Fresenius Medical Care reported first-quarter results above analysts' expectations on Tuesday, as revenue grew organically in all its segments, it said. |
reuters.com |
2025-05-06 05:04:59 |
Czytaj oryginał (ang.) |
| Watch These 3 MedTech Stocks for Q1 Earnings: Beat or Miss? |
MedTech companies' quarterly results are likely to reflect strength in customer demand. Let's see how FMS, MASI and CLOV are placed ahead of their earnings releases. |
zacks.com |
2025-05-05 16:10:37 |
Czytaj oryginał (ang.) |
| Should You Buy, Sell, or Hold FMS Stock Before Q1 Earnings? |
Fresenius Medical Care heads into the first quarter of 2025 with momentum from cost savings, innovation like the 5008X launch, and a steady recovery in U.S. treatment volumes. |
zacks.com |
2025-05-02 16:05:34 |
Czytaj oryginał (ang.) |
| Should Value Investors Buy Fresenius Medical Care AG & Co. (FMS) Stock? |
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. |
zacks.com |
2025-04-23 14:45:46 |
Czytaj oryginał (ang.) |
| Here's Why Fresenius (FMS) is a Strong Value Stock |
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage. |
zacks.com |
2025-04-17 14:40:46 |
Czytaj oryginał (ang.) |
| Why Fresenius Medical Care Stock Might be a Great Pick |
FMS has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well. |
zacks.com |
2025-04-17 13:50:55 |
Czytaj oryginał (ang.) |
| Volatile Markets? Try These Relative Price Strength Stocks |
IHS, ATLC, REX and FMS are four stocks with explosive relative price strength. |
zacks.com |
2025-04-16 14:10:33 |
Czytaj oryginał (ang.) |
| Avyance Helps Drive Successful Adoption of Oracle Cloud Financial Management System (FMS) at National Gallery of Art |
WASHINGTON--(BUSINESS WIRE)-- #ArtMeetsTech--Avyance Helps Launch First Oracle Cloud Federal Financials System at the National Gallery of Art. |
businesswire.com |
2025-04-16 14:10:00 |
Czytaj oryginał (ang.) |
| 4 Top-Ranked High Earnings Yield Value Stocks to Buy Right Away |
Unlock your portfolio value with value stocks like Alibaba, Fresenius Medical, Helix Energy and Heritage Insurance. All these stocks boast high earnings yield. |
zacks.com |
2025-04-15 14:45:38 |
Czytaj oryginał (ang.) |
| Here's Why Fresenius (FMS) is a Strong Momentum Stock |
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores. |
zacks.com |
2025-04-11 14:50:37 |
Czytaj oryginał (ang.) |
| Top 3 Medical Instruments Industry Stocks to Ride the GenAI Boom |
FMS, MASI and VCYT from the Zacks Medical Instruments industry are worth buying based on genAI adoption, strategic developments and strong fundamentals. Yet, geopolitical complications and wage and supply issues mar the prospects. |
zacks.com |
2025-02-27 14:50:18 |
Czytaj oryginał (ang.) |
| Fresenius Medical Q4 Earnings Beat Estimates, Revenues Up Y/Y |
FMS' fourth-quarter results showcase a strong segmental performance along with providing full year 2025 outlook for revenue growth and operating income. |
zacks.com |
2025-02-26 14:35:26 |
Czytaj oryginał (ang.) |
| Why Fresenius (FMS) is a Top Value Stock for the Long-Term |
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage. |
zacks.com |
2025-02-26 12:45:53 |
Czytaj oryginał (ang.) |
| Fresenius Medical Care delivers 18% earnings growth in 2024 and continues the acceleration momentum into 2025 |
Organic revenue growth1 of 4% driven by Care Enablement and Care Delivery Underlying U.S. same market treatment growth further accelerated in Q4 and turned positive for the full year Accumulated savings of the FME25 program already reached EUR 567 million and 2025 target raised to EUR 750 million With 18% operating income2 growth top end of the 2024 outlook range reached Reported operating income grew by 2%, reported net income3 by +8% Net financial leverage ratio reduced from 3.2x to 2.9x and dividend is planned to be raised by 21% High teens to high twenties percent earnings growth in 2025, translating into an 11 to 12% margin BAD HOMBURG, Germany , Feb. 25, 2025 /PRNewswire/ -- "Fresenius Medical Care has again delivered against its commitments and we met the top end of our 2024 target to profitably grow our business. We successfully executed against our strategic turnaround and transformation plan, advancing our legacy portfolio optimization and realizing significant FME25 savings ahead of plan. |
prnewswire.com |
2025-02-25 09:00:00 |
Czytaj oryginał (ang.) |
| Fresenius Medical Care slightly beats market estimates in fourth quarter |
Fresenius Medical Care , the world's largest dialysis specialist, reported fourth quarter results slightly above market expectations on Tuesday, citing positive development both in its care delivery and care enablement segments. |
reuters.com |
2025-02-25 03:14:22 |
Czytaj oryginał (ang.) |
| Fresenius Medical Care Announces Divestment of Select Laboratory Assets to Quest Diagnostics |
Quest to provide comprehensive dialysis-related laboratory and water testing services to Fresenius Medical Care owned and affiliated clinics in the United States BAD HOMBURG, Germany and SECAUCUS, N.J. , Feb. 24, 2025 /PRNewswire/ -- Fresenius Medical Care (XETRA: FME; NYSE: FMS), the world's leading provider of products and services for individuals with renal disease, and Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, today announced that, under terms of a definitive acquisition agreement, Quest will acquire select assets of FME's wholly owned Spectra Laboratories, a leading provider of renal-specific laboratory testing services in the U.S. In addition, under a separate agreement, Quest will provide comprehensive laboratory services related to end-stage kidney disease (ESKD) and specialized water testing for patients and providers served by dialysis centers operated by Fresenius Medical Care and its wholly owned and joint-venture partners in the United States. |
prnewswire.com |
2025-02-24 10:00:00 |
Czytaj oryginał (ang.) |
| Focus Graphite Advanced Materials Provides Update on Patent Pending Silicon-Enhanced Spheroidized Graphite Technology for Battery Anodes |
The Company's patent pending silicon-enhanced spheroidized graphite technology represents a breakthrough in lithium-ion battery performance. OTTAWA, ON / ACCESS Newswire / February 10, 2025 / Focus Graphite Advanced Materials Inc. (TSXV:FMS)(OTCQB:FCSMF)(FSE:FKC) ("Focus" or the "Company"), a Canadian critical minerals resource company developing innovative advanced battery materials and technology, is pleased to provide an update on the status of its patent applications for its proprietary silicon-enhanced spheroidized graphite technology for lithium-ion battery anodes. |
accessnewswire.com |
2025-02-10 14:45:00 |
Czytaj oryginał (ang.) |
| Fresenius Medical Care: A 'Buy' Going Into 2025 |
Fresenius Medical Care is a leader in global kidney care, showing significant growth and an 18.5% increase since my last article. The company is attractively valued, trading at less than 18.5x P/E, with a fair value estimate of at least $34/share. Risks include political factors in the US healthcare system and technological advancements, but the company's diversification and home-care model are strong positives. |
seekingalpha.com |
2025-01-31 08:20:48 |
Czytaj oryginał (ang.) |
| Fresenius (FMS) Upgraded to Strong Buy: Here's What You Should Know |
Fresenius (FMS) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term. |
zacks.com |
2025-01-07 15:16:30 |
Czytaj oryginał (ang.) |
| Best Income Stocks to Buy for January 7th |
PRMB, FMS and RBA made it to the Zacks Rank #1 (Strong Buy) income stocks list on January 7, 2024. |
zacks.com |
2025-01-07 06:26:09 |
Czytaj oryginał (ang.) |
| Best Value Stocks to Buy for January 7th |
FMS, SVM and CNO made it to the Zacks Rank #1 (Strong Buy) value stocks list on January 7, 2024. |
zacks.com |
2025-01-07 06:02:08 |
Czytaj oryginał (ang.) |
| Best Momentum Stocks to Buy for December 27th |
PAYO, TTDKY and FMS made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on December 27, 2024. |
zacks.com |
2024-12-27 13:16:30 |
Czytaj oryginał (ang.) |
| Best Income Stocks to Buy for December 27th |
TTDKY, FMS and FHB made it to the Zacks Rank #1 (Strong Buy) income stocks list on December 27, 2024. |
zacks.com |
2024-12-27 06:05:44 |
Czytaj oryginał (ang.) |
| Best Value Stocks to Buy for December 27th |
AAL, FMS and TTDKY made it to the Zacks Rank #1 (Strong Buy) value stocks list on December 27, 2024. |
zacks.com |
2024-12-27 05:55:16 |
Czytaj oryginał (ang.) |
| Fresenius Medical Care Listed in The Dow Jones Sustainability World Index and for the 15th Time in The Dow Jones Sustainability Europe Index |
Ranking puts Fresenius Medical Care among the best-in-class sustainability performers in the world and Europe The company recorded progress towards its sustainability targets Sustainability is one of the essential drivers for future BAD HOMBURG, Germany , Dec. 23, 2024 /PRNewswire/ -- Fresenius Medical Care (FME), the world's leading provider of products and services for individuals with renal diseases, has been recognized as a sustainability leader with the inclusion in the Dow Jones Sustainability World Index and with the inclusion in the Dow Jones Sustainability Europe Index for the 15th time. Dow Jones Sustainability Index (DJSI) is one of the world's leading ESG (Environmental, Social, Governance) stock indices. |
prnewswire.com |
2024-12-23 11:00:00 |
Czytaj oryginał (ang.) |
| Fresenius Medical Care returns to Dax 40 Index |
BAD HOMBURG, Germany , Dec. 20, 2024 /PRNewswire/ -- Fresenius Medical Care (FME), the world's leading provider of products and services for people with kidney disease, will return to the top tier of the German Stock Index, the DAX 40, as of December 27, 2024. The index represents the performance of the 40 largest publicly traded companies listed on the Frankfurt Stock Exchange and accounts for around 80 percent of the market capitalization of listed stock corporations in Germany. |
prnewswire.com |
2024-12-20 13:23:00 |
Czytaj oryginał (ang.) |
| 4 Value Stocks to Buy as Wall Street Awaits Fed's Rate Decision |
Value investing is essentially about selecting stocks that are usually cheap but fundamentally sound. TSN, GM, FMS and DLX boast a low P/CF ratio. |
zacks.com |
2024-12-17 13:46:17 |
Czytaj oryginał (ang.) |
| 5 Low Price-to-Book Value Stocks to Buy as 2024 Draws to a Close |
The P/B ratio helps to identify low-priced stocks with high growth prospects. GM, FMS, CIO, TRTX and ZIM are some such stocks. |
zacks.com |
2024-12-17 11:30:33 |
Czytaj oryginał (ang.) |
| Leadership in Dialysis Services and Products Drives FMS Stock |
Fresenius Medical Care leads global dialysis services, driving growth through innovation, restructuring and a strong global footprint in 120+ countries. |
zacks.com |
2024-12-17 11:00:45 |
Czytaj oryginał (ang.) |
| Are Investors Undervaluing Fresenius Medical Care AG & Co. (FMS) Right Now? |
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. |
zacks.com |
2024-12-05 12:45:27 |
Czytaj oryginał (ang.) |
| Here's Why Fresenius (FMS) is a Strong Value Stock |
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service. |
zacks.com |
2024-12-03 12:45:32 |
Czytaj oryginał (ang.) |
| Why Fresenius (FMS) is a Top Value Stock for the Long-Term |
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage. |
zacks.com |
2024-11-14 12:46:06 |
Czytaj oryginał (ang.) |
| Is Fresenius Medical Care AG & Co. (FMS) Stock Undervalued Right Now? |
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. |
zacks.com |
2024-11-11 12:45:31 |
Czytaj oryginał (ang.) |
| Fresenius Medical Q3 Earnings Beat Estimates, Operating Margin Rises |
FMS' third-quarter results showcase a strong segmental performance. The company raises its full-year 2024 outlook for operating income. |
zacks.com |
2024-11-06 14:11:10 |
Czytaj oryginał (ang.) |
| Fresenius (FMS) is a Top-Ranked Momentum Stock: Should You Buy? |
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores. |
zacks.com |
2024-11-06 12:55:34 |
Czytaj oryginał (ang.) |
| Hard work paying off despite challenges from U.S. weather-related events: Fresenius Medical Care CEO |
Helen Giza, the CEO of Fresenius Medical Care, discusses the German healthcare firm's third-quarter earnings. |
youtube.com |
2024-11-05 22:33:55 |
Czytaj oryginał (ang.) |
| Fresenius Medical Care AG (FMS) Q3 2024 Earnings Call Transcript |
Fresenius Medical Care AG (NYSE:FMS ) Q3 2024 Earnings Conference Call November 5, 2024 8:00 AM ET Company Participants Dominik Heger - Head, Investor Relations Helen Giza - Chief Executive Officer and Chair Martin Fischer - Chief Financial Officer Conference Call Participants Richard Felton - Goldman Sachs Victoria Lambert - Berenberg Robert Davies - Morgan Stanley Hugo Solvet - BNP Paribas Oliver Metzger - ODDO BHF Bank Sezgi Oezener - HSBC Giang Nguyen - Citigroup David Adlington - JPMorgan Marianne Bulot - Bank of America Falko Friedrichs - Deutsche Bank Christian Ehmann - Warburg Research Operator Ladies and gentlemen, welcome to the report of the Third Quarter 2024 of Fresenius Medical Care Conference Call. I'm Sandra, the Chorus Call operator. |
seekingalpha.com |
2024-11-05 16:34:42 |
Czytaj oryginał (ang.) |
| Fresenius Medical Care reports strong operating income margin growth in the third quarter of 2024 |
Organic revenue growth of +2% supported by Care Enablement and Care Delivery Underlying U.S. dialysis treatment volume growth turns positive Exceeding full year FME25 savings target, with additional EUR 64 million contribution in Q3 Both segments further increased operating income1 and operating income margin1 Net financial leverage ratio further improved to 2.8x FY 2024 operating income1 growth outlook with 16-18% tightened toward the upper end of the previous range BAD HOMBURG, Germany , Nov. 5, 2024 /PRNewswire/ -- "In the third quarter, we continued the improvement of our financial performance, recording a meaningful progress in the operating income margin towards our 2025 margin targets. The Care Delivery margin extended well into the 2025 margin target band while Care Enablement maintained the significant margin progress realized in the first half year. |
prnewswire.com |
2024-11-05 09:00:00 |
Czytaj oryginał (ang.) |
| Should Value Investors Buy Fresenius Medical Care AG & Co. (FMS) Stock? |
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. |
zacks.com |
2024-10-22 14:46:33 |
Czytaj oryginał (ang.) |
| Fresenius Medical Care Showcases Research and Innovations in Kidney Care at American Society of Nephrology (ASN) Kidney Week 2024 |
A dedicated session will highlight new advancements in hemodiafiltration therapy showcasing its potential to improve patient outcomes through enhanced toxin removal in dialysis treatments. Company-wide researchers and clinical experts share insights from large global databases, revealing crucial trends in kidney failure etiology, cardiovascular risks, and treatment modalities across different regions. |
prnewswire.com |
2024-10-21 15:04:00 |
Czytaj oryginał (ang.) |
| Here's Why Fresenius (FMS) is a Strong Value Stock |
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service. |
zacks.com |
2024-10-08 14:45:52 |
Czytaj oryginał (ang.) |